Amendment No. 1 to Consulting Agreement Between Calypte Biomedical Corporation and Michael Rudolph
Exhibit 4.1(e)
Amendment No. 1 to Consulting Agreement
Between Calypte Biomedical Corporation
and Xxxxxxx Xxxxxxx
This Agreement amends and modifies the Consulting Agreement between Calypte Biomedical Corporation (“Calypte” or the “Company”) and Xxxxxxx Xxxxxxx (“Consultant”) dated November 20, 2002 and is effective as of February 14, 2003.
Whereas, the Company desires to extend the time period during which Consultant will provide services to the Company pursuant to the above referenced Consulting Agreement and Consultant is agreeable to extending the time for providing such services.
Now therefore, in consideration of the premises and mutual promises set forth herein, the parties hereto agree as follows:
1. | The term of Consultant’s Consulting Agreement shall be extended and, by virtue of this Amendment, shall terminate on July 31, 2003 rather than April 20, 2003. |
2. | In consideration for these services to be performed by Consultant, the Company will immediately grant to Consultant 1,750,000 shares of its registered common stock. All compensation pursuant to the Consulting Agreement and this Amendment is fully earned upon execution of this amendment. |
3. | The Consultant will provide to Calypte’s Executive Chairman a written report of services rendered and results thereof each 90 days of this extended contract within 30 days of the contract’s quarter end. |
4. | All other terms and conditions of the Consultant Agreement dated November 20, 2002 remain unchanged. |
Consultant: |
Calypte Biomedical Corporation | |||||||
/s/ XXXXXXX XXXXXXX |
By: |
/s/ XXXXXXX X. XXXXXXXXXX | ||||||
Xxxxxxx Xxxxxxx |
Xxxxxxx Xxxxxxxxxx Executive Vice President & CFO |